YU402A - Novi derivati 2,3-benzodiazepina - Google Patents
Novi derivati 2,3-benzodiazepinaInfo
- Publication number
- YU402A YU402A YU402A YUP402A YU402A YU 402 A YU402 A YU 402A YU 402 A YU402 A YU 402A YU P402 A YUP402 A YU P402A YU 402 A YU402 A YU 402A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- bond
- positions
- hydrogen
- lower alkyl
- present
- Prior art date
Links
- RPBDCDQMCRHNLM-UHFFFAOYSA-N C1=NNC=C2C=CC=CC2=C1 Chemical class C1=NNC=C2C=CC=CC2=C1 RPBDCDQMCRHNLM-UHFFFAOYSA-N 0.000 title abstract 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 4
- 239000001257 hydrogen Substances 0.000 abstract 4
- 229910052739 hydrogen Inorganic materials 0.000 abstract 4
- 229910052757 nitrogen Inorganic materials 0.000 abstract 4
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 2
- 125000000623 heterocyclic group Chemical group 0.000 abstract 2
- 150000002431 hydrogen Chemical class 0.000 abstract 2
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 2
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 2
- 229920006395 saturated elastomer Polymers 0.000 abstract 2
- 229910052717 sulfur Inorganic materials 0.000 abstract 2
- 239000011593 sulfur Substances 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000001589 carboacyl group Chemical group 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 230000000324 neuroprotective effect Effects 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Addiction (AREA)
- Psychology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Urology & Nephrology (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
Predmetni pronalazak se odnosi na nove derivate 2,3-benzodiazepina, opste formule (I), (naznacene time sto R1 oznacava metil, formil, karboksi, cijano, -CH=NOH, -CH=NNHCONH2 ili -NR5R6 grupu, naznacenu time sto R5 i R6 nezavisno jedno od drugog, predstavljaju vodonik ili nizi alkil ili zajedno sa atomom azota za koji su vezani obrazuju petoclani iil sestoclani zasiceni ili nezasiceni heterociklicni prsten, koji opciono sadrzi jedan ili vise dodatnih atoma azota, sumpora i/ili kiseonika, R2 je nitro ili amino grupa, R3 oznacava vodonik, nizi alkanoil ili grupu CO-NR7R8, naznacenu time sto R7 i R8 nezavisno jedno od drugog, predstavljaju vodonik, nizi alkoksi, nizi alkil ili nizi cikloalkil ili zajedno sa atomom azota za koji su vezani obrazuju petoclani ili sestoclani zasiceni ili nezasiceni heterociklicni prsten, koji opciono sadrzi jedan ili vise dodatnih atoma azota, sumpora i/li kiseonika, R4 je vodonik ili nizi alkil, a isprekidane linije imaju sledece znacenje: ako R3 i R4 nisu prisutni, veza izmedju pozicija C8 i C9 je jednoguba, a veza izmedju pozicija C8 i N7 je dvoguba, ako su R3 i R4 prisutni, veze izmedju pozicija C8 i C9 i pozicija C8 i N7 su jednogube veze, i ako je R3 prisutno, a R4 nedostaje, veza izmedju pozicija C8 i C9 je dvoguba, a veza izmedju pozicija C8 i N7 je jednoguba) i njihove soli. Jedinjenja predmetnog pronalaska imaju neuroprotekciono dejstvo.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU9902291A HU227128B1 (en) | 1999-07-07 | 1999-07-07 | New 2,3-benzodiazepine derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
YU402A true YU402A (sh) | 2004-11-25 |
Family
ID=89998666
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YU402A YU402A (sh) | 1999-07-07 | 2000-07-04 | Novi derivati 2,3-benzodiazepina |
Country Status (22)
Country | Link |
---|---|
US (1) | US7053082B1 (sh) |
EP (1) | EP1200442B8 (sh) |
JP (1) | JP2003504372A (sh) |
KR (1) | KR100818001B1 (sh) |
CN (1) | CN1162432C (sh) |
AT (1) | ATE243699T1 (sh) |
AU (1) | AU5836300A (sh) |
BG (1) | BG65405B1 (sh) |
CA (1) | CA2378305A1 (sh) |
CZ (1) | CZ20014698A3 (sh) |
DE (1) | DE60003561T2 (sh) |
DK (1) | DK1200442T3 (sh) |
HK (1) | HK1047581B (sh) |
HR (1) | HRP20020015B1 (sh) |
HU (1) | HU227128B1 (sh) |
PL (1) | PL351839A1 (sh) |
RO (1) | RO121853B1 (sh) |
RU (1) | RU2243228C2 (sh) |
SK (1) | SK286680B6 (sh) |
UA (1) | UA72261C2 (sh) |
WO (1) | WO2001004122A2 (sh) |
YU (1) | YU402A (sh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU225100B1 (hu) | 2000-12-21 | 2006-06-28 | Egyt Gyogyszervegyeszeti Gyar | 2,3-Benzodiazepinszármazékok, ilyen hatóanyagot tartalmazó gyógyászati készítmények és alkalmazásuk |
US6858605B2 (en) | 2003-02-04 | 2005-02-22 | Ivax Drug Research Institute, Ltd. | Substituted 2,3-benzodiazepine derivatives |
EA016087B1 (ru) * | 2005-12-30 | 2012-02-28 | Эгиш Дьёдьсердьяр Ньильваношан Мюкёдё Ресвеньтаршашаг | Оптические изомеры дигидро-2,3-бензодиазепинов и их стереоселективный синтез |
FR2972454B1 (fr) * | 2011-03-08 | 2013-03-01 | Servier Lab | Nouveaux derives dihydro-oxazolobenzodiazepinones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU179018B (en) * | 1978-10-19 | 1982-08-28 | Gyogyszerkutato Intezet | Process for producing new 5h-2,3-benzodiazepine derivatives |
HU191702B (en) * | 1984-06-27 | 1987-03-30 | Gyogyszerkutato Intezet | New process for preparing 1-aryl-5 h-2,3-benzodiazepines |
HU191698B (en) * | 1984-07-27 | 1987-03-30 | Gyogyszerkutato Intezet | Process for producing new 1-aryl-5h-2beta-benzodiazepines |
HU195788B (en) * | 1986-05-21 | 1988-07-28 | Gyogyszerkutato Intezet | Process for producing 1-/hydroxy-stiryl/-5h-2,3-benzobiazepines and pharmaceutical compositions containing them |
HU206719B (en) * | 1990-12-21 | 1992-12-28 | Gyogyszerkutato Intezet | Process for producing 1-/4-acylamino-phenyl/-7,8-methylenedioxy-5h-2,3-benzodiazepine derivatives, acid addicional salts and pharmaceutical compositions containing them |
HU219778B (hu) * | 1990-12-21 | 2001-07-30 | Gyógyszerkutató Intézet Közös Vállalat | Eljárás N-acil-2,3-benzodiazepin-származékok, savaddíciós sóik és az ezeket tartalmazó gyógyászati készítmények előállítására, valamint a vegyületek egy csoportja, és az ezeket tartalmazó gyógyászati készítmények |
HU219777B (hu) * | 1993-07-02 | 2001-07-30 | Gyógyszerkutató Intézet Kft. | Optikailag aktív 1-(4-nitro-fenil)-4-metil-7,8-metiléndioxi-3,4-dihidro-5H-2,3-benzodiazepin és eljárás előállítására |
DE4428835A1 (de) * | 1994-08-01 | 1996-02-08 | Schering Ag | Neue 3-substituierte 3H-2,3-Benzodiazepinderivate, deren Herstellung und Verwendung als Arzneimittel |
DK1157992T3 (da) * | 1994-08-31 | 2005-10-24 | Lilly Co Eli | Dihydro-2,3-benzodiazepinederivativer |
US5891871A (en) * | 1996-03-21 | 1999-04-06 | Cocensys, Inc. | Substituted 2,3-benzodiazepin-4-ones and the use thereof |
UA67749C2 (uk) * | 1997-08-12 | 2004-07-15 | Егіш Дьйодьсердьяр Рт. | Похідна 8-заміщеного-9н-1,3-діоксол/4,5-h//2,3/бензодіазепіну з властивостями амра/каїнатного антагоніста, спосіб одержання похідних, фармацевтична композиція (варіанти), спосіб її одержання та спосіб лікування |
-
1999
- 1999-07-07 HU HU9902291A patent/HU227128B1/hu not_active IP Right Cessation
-
2000
- 2000-04-07 UA UA2002020975A patent/UA72261C2/uk unknown
- 2000-07-04 DE DE60003561T patent/DE60003561T2/de not_active Expired - Lifetime
- 2000-07-04 AT AT00944129T patent/ATE243699T1/de not_active IP Right Cessation
- 2000-07-04 CN CNB008100152A patent/CN1162432C/zh not_active Expired - Fee Related
- 2000-07-04 DK DK00944129T patent/DK1200442T3/da active
- 2000-07-04 AU AU58363/00A patent/AU5836300A/en not_active Abandoned
- 2000-07-04 PL PL00351839A patent/PL351839A1/xx not_active Application Discontinuation
- 2000-07-04 JP JP2001509731A patent/JP2003504372A/ja active Pending
- 2000-07-04 CZ CZ20014698A patent/CZ20014698A3/cs unknown
- 2000-07-04 EP EP00944129A patent/EP1200442B8/en not_active Expired - Lifetime
- 2000-07-04 YU YU402A patent/YU402A/sh unknown
- 2000-07-04 KR KR1020027000200A patent/KR100818001B1/ko not_active IP Right Cessation
- 2000-07-04 RU RU2002103311/04A patent/RU2243228C2/ru not_active IP Right Cessation
- 2000-07-04 SK SK17-2002A patent/SK286680B6/sk not_active IP Right Cessation
- 2000-07-04 CA CA002378305A patent/CA2378305A1/en not_active Abandoned
- 2000-07-04 WO PCT/HU2000/000074 patent/WO2001004122A2/en active IP Right Grant
- 2000-07-04 RO ROA200200003A patent/RO121853B1/ro unknown
- 2000-07-04 US US10/030,436 patent/US7053082B1/en not_active Expired - Fee Related
-
2002
- 2002-01-07 BG BG106281A patent/BG65405B1/bg unknown
- 2002-01-07 HR HR20020015A patent/HRP20020015B1/xx not_active IP Right Cessation
- 2002-10-18 HK HK02107601.4A patent/HK1047581B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE60003561T2 (de) | 2004-04-29 |
DK1200442T3 (da) | 2003-10-20 |
BG106281A (en) | 2003-01-31 |
KR20020022765A (ko) | 2002-03-27 |
CZ20014698A3 (cs) | 2002-06-12 |
HK1047581A1 (en) | 2003-02-28 |
EP1200442B1 (en) | 2003-06-25 |
ATE243699T1 (de) | 2003-07-15 |
CA2378305A1 (en) | 2001-01-18 |
AU5836300A (en) | 2001-01-30 |
JP2003504372A (ja) | 2003-02-04 |
WO2001004122A3 (en) | 2001-05-10 |
BG65405B1 (bg) | 2008-06-30 |
SK172002A3 (en) | 2002-06-04 |
HU227128B1 (en) | 2010-07-28 |
CN1370174A (zh) | 2002-09-18 |
PL351839A1 (en) | 2003-06-16 |
HRP20020015A2 (en) | 2004-08-31 |
CN1162432C (zh) | 2004-08-18 |
KR100818001B1 (ko) | 2008-03-31 |
UA72261C2 (uk) | 2005-02-15 |
RO121853B1 (ro) | 2008-06-30 |
EP1200442A1 (en) | 2002-05-02 |
EP1200442B8 (en) | 2003-08-20 |
RU2243228C2 (ru) | 2004-12-27 |
HU9902291D0 (en) | 1999-09-28 |
HUP9902291A2 (hu) | 2001-12-28 |
HRP20020015B1 (en) | 2005-02-28 |
DE60003561D1 (de) | 2003-07-31 |
US7053082B1 (en) | 2006-05-30 |
WO2001004122A2 (en) | 2001-01-18 |
HK1047581B (zh) | 2004-04-30 |
SK286680B6 (sk) | 2009-03-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1074542A4 (en) | SULFONAMID CONTAINING INDOLDER DERIVATIVES | |
CA2316902A1 (en) | Alpha-aminoamide derivatives useful as analgesic agents | |
TW341565B (en) | Indole derivatives processes and intermediates for their preparation and pharmaceutical compositions containing them | |
HU9602466D0 (en) | Naphthalene derivatives as prostaglandin i2 agonits | |
NZ330973A (en) | Azolobenzazepine derivatives as neurologically active agents | |
NZ514662A (en) | Amine derivatives | |
AU2267495A (en) | Benzamide derivatives as vasopressin antagonists | |
BG104069A (en) | 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-1h-indole derivatives interacting with the dopamine d4 receptor | |
MX9806171A (es) | Derivados 2,3-benzodiazepina y sus usos como inhibidores del receptor-ampa. | |
AU626980B2 (en) | Tetrahydrobenzimidazole derivatives | |
EP0924207A4 (en) | CHROMENE-3-CARBOXYLATE DERIVATIVES | |
HUP0004477A2 (hu) | Herbicid hatású 3-(1,2-benzizotiazol- vagy-izoxazol-5-il)-csoporttal helyettesített pirimidinszármazékok, intermedierjeik, előállításuk és alkalmazásuk | |
HUP0203645A2 (hu) | Fenilpiperazinil-származékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
WO2002000638A8 (en) | Substituted phthalides as anti-convulsive drugs | |
YU402A (sh) | Novi derivati 2,3-benzodiazepina | |
MY131762A (en) | Pharmaceutical compounds | |
IL132799A0 (en) | 17Beta-allyloxy(thio)alkyl-androstane derivatives for the modulation of meiosis | |
AU686934B2 (en) | 2-heterocyclicethylamine derivatives and their use as pharmaceuticals | |
AU2002214320A1 (en) | Imidazole derivatives, process for their preparation and their use | |
AU3285000A (en) | 22r-hydroxycholesta-8,14-diene derivatives for the inhibition of meiosis | |
TW340844B (en) | Amide derivatives | |
DE69526413D1 (de) | Heterocyclische Carboxyalkylderivate | |
AU3648093A (en) | Pyrrolidine derivatives useful as 5-HT3-antagonists | |
HU9602534D0 (en) | Use of biphenyl methyl imidazole derivatives for producing pharmaceutical compositions having ocular tension derpessant activity | |
BG103937A (en) | 5-naphthalen-1-yl-1,3-dioxane derivatives, their preparation and application in therapy |